Alessio Fasano: ‘The future of personalized treatments and disease interception depends on microbiome research’

During the 12th Probiotics, prebiotics and new foods congress, held last September in Rome, Microbiomepost sat down with Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, to discuss how to improve the knowledge about the mechanistic link between gut microbiome and disease pathogenesis and the impact on the future clinical practice.